Former CortiCare – now Caura startup had a pivot shortly after the OA, and went on successfully, reaching a working prototype. They have scheduled 10+ trials with pro-athlete teams and have raised £1.6 million.
Termopatch has expanded the team, involving medical doctor and business developer, and have filed 2 patents. In 2018 they have obtained investment from U4I Foundation to pre-clinically validate the patch. The prototypes are now ready and they are preparing to start the tests on mice.
Biorek has been working on prospective and retrospective clinical studies to validate their innovation and has been successfully fundraising.
enGenome have launched their product for genomic variant interpretation in June 2019. They also have obtained first paying customers and CE IVD mark. They have received a seed Investment from Business Angels and Fondazione Golinelli and currently have 7 employees working full time at the company.